GlassScriptPrepare for your visit
Eva S Mina
Internal Medicine · Fort Worth, TX · NPI 1891784922
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,890.43
in general payments reported to CMS, 2019-2025 · $569 in 2025
The $569 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Glaxosmithkline, LLC. $429.59
- Novo Nordisk INC $428.93
- Astrazeneca Pharmaceuticals LP $340.78
- Abbvie INC. $297.85
- Boehringer Ingelheim Pharmaceuticals, INC. $244.87
- Lilly USA, LLC $229.23
Drugs and devices associated with these payments
Veozah Freestyle Libre 3 Trelegy Ellipta Cologuard Collection Kit Jardiance Arexvy Ozempic Rybelsus Shingrix Airsupra Dexcom G6 Transmitter Wegovy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Eva Mina listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/221917/eva-s-mina